Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol.
Kristin A ShimanoRachael F GraceJenny M DespotovicEllis J NeufeldRobert J KlaassenCarolyn M BennettClement MaWendy B LondonCindy NeunertPublished in: BMJ open (2021)
NCT03939637.